424
Views
18
CrossRef citations to date
0
Altmetric
Review Article

β-Thalassemia trait association with autoimmune diseases: β-globin locus proximity to the immunity genes or role of hemorphins?

, &
Pages 181-190 | Received 10 May 2011, Accepted 20 Jun 2011, Published online: 28 Jul 2011

References

  • Zlotogora, J. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 2009, 126, 247–253.
  • Iolascon, A., De Falco, L., Beaumont, C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 2009, 94, 395–408.
  • Ibba, R.M., Zoppi, M.A., Floris, M., Manca, F., Axiana, C., Cao, A., Monni, G. Neural tube defects in the offspring of thalassemia carriers. Fetal Diagn Ther 2003, 18, 5–7.
  • Lam, Y.H., Tang, M.H. Risk of neural tube defects in the offspring of thalassaemia carriers in Hong Kong Chinese. Prenat Diagn 1999, 19, 1135–1137.
  • Bencaiova, G., Krafft, A., Burkhardt, T., Zimmermann, R. Hemoglobinopathies, body iron stores and gestational diabetes mellitus. Haematologica 2005, 90, 1138–1139.
  • Tong, P.C., Ng, M.C., Ho, C.S., So, W.Y., Li, J.K., Lam, C.W., Cockram, C.S., Chan, J.C. C-reactive protein and insulin resistance in subjects with thalassemia minor and a family history of diabetes. Diabetes Care 2002, 25, 1480–1481.
  • Morreale, S. Incidence of thalassemic trait in patients with diabetes mellitus. Riv Eur Sci Med Farmacol 1987, 9, 153–155.
  • Gerster, J.C., Dardel, R., Guggi, S. Recurrent episodes of arthritis in thalassemia minor. J Rheumatol 1984, 11, 352–354.
  • Feske, S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007, 7, 690–702.
  • Orzincolo, C., Castaldi, G., Scutellari, P.N., Vita, F., Bagni, B. Osteoporosis and the thalassemia “trait”. Radiol Med 1993, 85, 23–27.
  • Oktenli, C., Bulucu, F. Renal tubular dysfunction in a patient with β-thalassemia minor. Nephron 2002, 92, 222–223.
  • Cetin, T., Oktenli, C., Ozgurtas, T., Yenicesu, M., Sanisoglu, S.Y., Oguz, Y., Yildiz, O., Kurt, I., Musabak, U., Bulucu, F., Kocar, I.H. Renal tubular dysfunction in β-thalassemia minor. Am J Kidney Dis 2003, 42, 1164–1168.
  • Di Iorio, B.R., Aucella, F., Stallone, C., Bellizzi, V.; Thalassaemia Minor in Hemodialysis Study Group. Thalassaemia minor: National survey of uraemic patients under substitutive treatment. G Ital Nefrol 2002, 19, 286–293.
  • Yang, R.B., Ng, C.K., Wasserman, S.M., Colman, S.D., Shenoy, S., Mehraban, F., Komuves, L.G., Tomlinson, J.E., Topper, J.N. Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem 2002, 277, 46364–46373.
  • Chandra, M., Mouradian, J., Hoyer, J.R., Lewy, J.E. Familial nephrotic syndrome and focal segmental glomerulosclerosis. J Pediatr 1981, 98, 556–560.
  • Kagan, A., Feld, S., Chemke, J., Bar-Khayim, Y. Occurrence of hereditary nephritis, pretibial epidermolysis bullosa and β-thalassemia minor in two siblings with end-stage renal disease. Nephron 1988, 49, 331–332.
  • Karamatic Crew, V., Burton, N., Kagan, A., Green, C.A., Levene, C., Flinter, F., Brady, R.L., Daniels, G., Anstee, D.J. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 2004, 104, 2217–2223.
  • Baleato, R.M., Guthrie, P.L., Gubler, M.C., Ashman, L.K., Roselli, S. Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. Am J Pathol 2008, 173, 927–937.
  • Quintero-Del-Rio, A.I., Kelly, J.A., Kilpatrick, J., James, J.A., Harley, J.B. The genetics of systemic lupus erythematosus stratified by renal disease: Linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002, 3 Suppl 1, S57–S62.
  • Marcolongo, R., Trotta, F., Scaramelli, M. Letter: β-thalassaemic trait and rheumatoid arthritis. Lancet 1975, 1, 1141.
  • Schlumpf, U., Gerber, N., Bünzli, H., Elsässer, U., Pestalozzi, A., Böni, A. Arthritis in thalassemia minor. Schweiz Med Wochenschr 1977, 107, 1156–1162.
  • Schuhmann, M.K., Stegner, D., Berna-Erro, A., Bittner, S., Braun, A., Kleinschnitz, C., Stoll, G., Wiendl, H., Meuth, S.G., Nieswandt, B. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol 2010, 184, 1536–1542.
  • Dorwart, B.B., Schumacher, H.R. Arthritis in β thalassaemia trait: Clinical and pathological features. Ann Rheum Dis 1981, 40, 185–189.
  • Carcassi, U., Cacace, E., Mela, Q., Passiu, G., Perpignano, G., Pintus, A. Thalassemia phenotypes in Sardinia. Birth Defects Orig Artic Ser 1982, 18, 165–168.
  • Górriz, L., De León, C., Herrero-Beaumont, G., del Vallado, P.F. Arthritis in β-thalassemia minor. Arthritis Rheum 1983, 26, 1292–1293.
  • Greep, N., Anderson, A.L., Gallagher, J.C. Thalassemia minor: A risk factor for osteoporosis? Bone Miner 1992, 16, 63–72.
  • Montecucco, C., Caporali, R., Rossi, S., Epis, O. Rheumatoid arthritis in β-thalassaemia trait. Rheumatology (Oxford) 1999, 38, 1021–1022.
  • Contu, L., Arras, M., Mulargia, M., La Nasa, G., Carcassi, C., Leone, A.L., Ledda, A., Goddi, F. Study of HLA segregation in 479 thalassemic families. Tissue Antigens 1992, 39, 58–67.
  • Castellino, G., Govoni, M., Trotta, F. Rheumatoid arthritis in β-thalassaemia trait. Rheumatology (Oxford) 2000, 39, 1286–1287.
  • Richter, J., Specker, C., Mödder, U., Schneider, M. Arthropathy in β-thalassemia minor. Med Klin (Munich) 2000, 95, 40–43.
  • Caporali, R., Bugatti, S., Rossi, S., Cavagna, L., Bogliolo, L., Montecucco, C. Rheumatoid arthritis in β-thalassemic trait: Clinical, serologic and immunogenetic profile. Joint Bone Spine 2004, 71, 117–120.
  • Castellino, G., Govoni, M., Padovan, M., Rizzo, N., Trotta, F. β thalassaemic trait and systemic lupus erythematosus. Ann Rheum Dis 2005, 64, 653–654.
  • Castellino, G., Govoni, M., Trotta, F. β-thalassaemic trait and systemic lupus erythematosus. Clin Exp Rheumatol 2004, 22, 382–383.
  • Pamuk, G.E., Pamuk, O.N., Set, T., Harmandar, O., Yesil, N. An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin Rheumatol 2008, 27, 1103–1108.
  • Buskila, D., Sarzi-Puttini, P. Fibromyalgia and autoimmune diseases: The pain behind autoimmunity. Isr Med Assoc J 2008, 10, 77–78.
  • Palma-Carlos, A.G., Palma-Carlos, M.L., Costa, A.C. “Minor” hemoglobinopathies: A risk factor for asthma. Eur Ann Allergy Clin Immunol 2005, 37, 177–182.
  • Itoh, K., Itoh, Y., Frank, M.B. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest 1991, 87, 177–186.
  • Frank, M.B., Itoh, K., Fujisaku, A., Pontarotti, P., Mattei, M.G., Neas, B.R. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 1993, 52, 183–191.
  • Hewavitharana, T., Deng, X., Soboloff, J., Gill, D.L. Role of STIM and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium 2007, 42, 173–182.
  • Feske, S. ORAI1 and STIM1 deficiency in human and mice: Roles of store-operated Ca2+ entry in the immune system and beyond. Immunol Rev 2009, 231, 189–209.
  • Baba, Y., Nishida, K., Fujii, Y., Hirano, T., Hikida, M., Kurosaki, T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol 2008, 9, 81–88.
  • Picard, C., McCarl, C.A., Papolos, A., Khalil, S., Lüthy, K., Hivroz, C., LeDeist, F., Rieux-Laucat, F., Rechavi, G., Rao, A., Fischer, A., Feske, S. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009, 360, 1971–1980.
  • Cahalan, M.D., Chandy, K.G. The functional network of ion channels in T lymphocytes. Immunol Rev 2009, 231, 59–87.
  • Wright, M.D., Geary, S.M., Fitter, S., Moseley, G.W., Lau, L.M., Sheng, K.C., Apostolopoulos, V., Stanley, E.G., Jackson, D.E., Ashman, L.K. Characterization of mice lacking the tetraspanin superfamily member CD151. Mol Cell Biol 2004, 24, 5978–5988.
  • Sheng, K.C., van Spriel, A.B., Gartlan, K.H., Sofi, M., Apostolopoulos, V., Ashman, L., Wright, M.D. Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC. Eur J Immunol 2009, 39, 50–55.
  • Delgado, P., Cubelos, B., Calleja, E., Martínez-Martín, N., Ciprés, A., Mérida, I., Bellas, C., Bustelo, X.R., Alarcón, B. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 2009, 10, 880–888.
  • Thomassen, E., Renshaw, B.R., Sims, J.E. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 1999, 11, 389–399.
  • Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J.E., Stark, G.R., Li, X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003, 4, 920–927.
  • May, W., Korenberg, J.R., Chen, X.N., Lunsford, L., Wood, W.J., Thompson, A., Wall, R., Denny, C.T. Human lymphocyte-specific pp52 gene is a member of a highly conserved dispersed family. Genomics 1993, 15, 515–520.
  • Liu, L., Cara, D.C., Kaur, J., Raharjo, E., Mullaly, S.C., Jongstra-Bilen, J., Jongstra, J., Kubes, P. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J Exp Med 2005, 201, 409–418.
  • Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., Volpe, F. TOLLIP, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000, 2, 346–351.
  • Bulut, Y., Faure, E., Thomas, L., Equils, O., Arditi, M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001, 167, 987–994.
  • Nyberg, F., Sanderson, K., Glämsta, E.L. The hemorphins: A new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 1997, 43, 147–156.
  • Dagouassat, N., Garreau, I., Sannier, F., Zhao, Q., Piot, J.M. Generation of VV-hemorphin-7 from globin by peritoneal macrophages. FEBS Lett 1996, 382, 37–42.
  • Sanderson, K., Nyberg, F., Khalil, Z. Modulation of peripheral inflammation by locally administered hemorphin-7. Inflamm Res 1998, 47, 49–55.
  • Liang, T.S., Gao, J.L., Fatemi, O., Lavigne, M., Leto, T.L., Murphy, P.M. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR. J Immunol 2001, 167, 6609–6614.
  • Arman, M.I., Butun, B., Doseyen, A., Bircan, I., Guven, A. Frequency and features of rheumatic findings in thalassaemia minor: A blind controlled study. Br J Rheumatol 1992, 31, 197–199.
  • Di Iorio, B., Guastaferro, P., Bellizzi, V. Relationship between resistance to erythropoietin and high anomalous hemoglobin levels in hemodialysis patients with β-thalassemia minor. Blood Purif 2003, 21, 376–380.
  • Gómez Rodríguez, N., Sánchez Bursón, J.M., Atanes Sandoval, A., Graña Gil, J., de Toro Santos, J., Galdo Fernández, F. Osteoporosis as the first manifestation of minor β-thalassemia. An Med Interna 1992, 9, 287–290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.